BIOMAT Database Logo BIOMAT Database Logo

Reduction of testicular human chorionic gonadotropin receptors by human chorionic gonadotropin in infertile men. 1988

M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
Department of Urology, Osaka University Medical School, Japan.

We measured testicular human chorionic gonadotropin (hCG) receptors in 30 infertile men either before or 1, 3, 5, 7, or 14 days after a single administration of 5000 IU of hCG. For 5 days the administration of hCG significantly reduced the testicular binding of 125I-hCG compared with that of the testes before administration. From the 7th day the binding capacity began to increase and returned to the preadministration level 14 days after the treatment. Occupied hCG binding sites accounted for about half of the reduction in binding sites on the day after administration of hCG. After this time, however, the occupancy did not contribute so much to the reduction in binding sites. These findings suggest that the reduction in testicular hCG binding sites after a single administration of 5000 IU of hCG is due to not only occupancy but also down-regulation of the binding sites.

UI MeSH Term Description Entries
D007248 Infertility, Male The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility. Sterility, Male,Sub-Fertility, Male,Subfertility, Male,Male Infertility,Male Sterility,Male Sub-Fertility,Male Subfertility,Sub Fertility, Male
D008297 Male Males
D011967 Receptors, Gonadotropin Those protein complexes or molecular sites on the surfaces of gonadal and other sensitive cells that bind gonadotropins and thereby modify the functions of those cells; hCG, LH, and FOLLICLE STIMULATING HORMONE are the major specific gonadotropins. Gonadotropin Receptors,Menotropin Receptors,Pituitary Gonadotropin Receptors,Receptors, Menotropin,Gonadotopin Receptor,Pituitary Gonadotropin Receptor,Receptors, Gonadotropins,Receptors, Pituitary Gonadotropin,Gonadotropin Receptor, Pituitary,Gonadotropin Receptors, Pituitary,Gonadotropins Receptors,Receptor, Gonadotopin,Receptor, Pituitary Gonadotropin
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013737 Testis The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS. Testicles,Testes,Testicle
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
Down-regulation of testicular follicle-stimulating hormone receptors by human menopausal gonadotropin in infertile men.
November 1985, Fertility and sterility,
M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
[Testicular response to human chorionic gonadotropin in infertile patients according to the testicular histologic pattern].
January 1985, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
Testicular follicle stimulating hormone receptors and effectiveness of human menopausal gonadotrophin-human chorionic gonadotrophin treatment in infertile men.
November 1986, Clinical endocrinology,
M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
Testicular steroidogenesis in adult men with human chorionic gonadotropin-producing tumors.
August 1995, The Journal of clinical endocrinology and metabolism,
M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
Reduction of testicular luteinizing hormone/human chorionic gonadotropin receptors by [D-Trp6]-luteinizing hormone releasing hormone in hypophysectomized rats.
October 1979, Biochemical and biophysical research communications,
M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
[Testicular response to various doses of human chorionic gonadotropin in normal men].
January 1985, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors.
January 1974, Surgical forum,
M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
Abnormality of testicular FSH receptors in infertile men.
August 1984, Acta endocrinologica,
M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
Human chorionic gonadotropin in weight reduction.
May 1977, The American journal of clinical nutrition,
M Namiki, and M Kitamura, and O Miyake, and M Nakamura, and A Okuyama, and T Sonoda, and M Takeyama, and H Fujioka, and K Matsumoto
[Testicular retention treated with human chorionic gonadotropin].
January 1984, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!